SAN ANTONIO 1000 CANCER GENOME PROJ (EIN 465020113) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2014

Legal Domicile

Principal Officer

AIMEE LOCKE

Phone

2108617676

Tax Period

2021-01-01 to 2021-12-31

SAN ANTONIO 1000 CANCER GENOME PROJ, founded in 2014, is a micro nonprofit in the Diseases & Disorders sector that reported $30K in total revenue in fiscal year 2021. Revenue surged 38% from the prior year, signaling strong growth momentum. The organization ran a surplus of $26K, a strong 88% operating margin.

Mission

THE CORPORATION IS ORGANIZED AND SHALL BE OPERATED TO ACCELERATE THE DEVELOPMENT OF A CURE FOR CANCER BY CONDUCTING WHOLE GENOME SEQUENCING.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2021)

Revenue Breakdown

Contributions & Grants $29,612

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $29,612

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $763

Other Expenses $3,440

TOTAL EXPENSES $3,440

Year-over-Year Comparison

	2021	2020	Change
Revenue	$29,612	$21,536	+0.4%
Expenses	$3,440	$3,782	-0.1%
Net Income	$26,172	$17,754	+0.5%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
AIMEE LOCKE	PRESIDENT	N/A	Officer Director	$0	$0	$0
GINA MANGOLD	SECRETARY	N/A	Officer Director	$0	$0	$0
IAN THOMPSON MD	DIRECTOR	N/A	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2021	$29,612	$3,440	$647,473	$26,172
2020	$21,536	$3,782	$621,301	$17,754
2019	$40,005	$2,470	$603,547	$37,535
2018	$39,273	$2,381	$566,012	$36,892

SAN ANTONIO 1000 CANCER GENOME PROJ